At close: December 20 at 4:00:00 PM EST
After hours: December 20 at 7:52:51 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 150k | 150k | 500k | 20M |
| Low Estimate | -- | -- | -- | 10M |
| High Estimate | 300k | 300k | 1M | 30M |
| Year Ago Sales | 196k | 196k | 743k | 500k |
| Sales Growth (year/est) | -23.47% | -23.47% | -32.71% | 3,900.00% |
Earnings History
| Currency in USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.9 | -0.73 | -0.43 | -0.37 |
| EPS Actual | 0 | 0 | 0 | -3 |
| Difference | 1.9 | 0.73 | 0.43 | -2.63 |
| Surprise % | 100.00% | 100.00% | 100.00% | -710.81% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CANF | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Initiated | EF Hutton: Buy | 7/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/24/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 6/2/2023 |
Related Tickers
BLRX BioLineRx Ltd.
0.2030
+0.50%
ENLV Enlivex Therapeutics Ltd.
1.2400
+5.08%
UNCY Unicycive Therapeutics, Inc.
0.6840
-3.66%
XTLB XTL Biopharmaceuticals Ltd.
1.4400
0.00%
APVO Aptevo Therapeutics Inc.
4.4100
-2.65%
PLUR Pluri Inc.
4.8200
+5.93%
EVGN Evogene Ltd.
1.3500
+4.65%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.2600
-10.64%
PPBT Purple Biotech Ltd
3.4200
-0.87%
PLX Protalix BioTherapeutics, Inc.
1.7600
+1.15%